RECOMBINETICS

Company Overview

Founded in 2008, Recombinetics is a global leader in proprietary gene repair and gene-editing technology. The company’s scientific research and development of TALEN technologies has resulted in global exclusive rights for use of the technology in the biomedical, animal agriculture and livestock vertical markets. Recombinetics is headquartered in St. Paul, Minn., and it has offices in Austin, Texas; Campo Grande, Brazil; and Hong Kong.

Recombinetics is developing animal models with defined genetic conditions identical to those found in human patients for the pharmaceutical and medical device industries, which need to replace the poor indicative animal models to reduce both skyrocketing costs and lengthy product development times. Recombinetics is also using its gene-editing technology to provide animal breeders with a precise, accurate and rapid method of changing specific traits in less time than is possible in a conventional breeding program. The company is targeting traits that impact productivity, animal health and animal welfare. Additionally, Recombinetics-developed and owned IP covers an array of products and methods including gene targeting, improvements to methods (including TALENs and CRISPR-Cas9) of gene editing and repair, and applications of these technologies to livestock improvement.

Company's Business Segments

• Genetic Technologies : This segment includes Regenerative Medicine, Disease Research, Animal Agriculture.